Commonwealth Bio Closes Genetic Testing Sale | GenomeWeb

NEW YORK (GenomeWeb News) – Commonwealth Biotechnologies said today that it has closed the sale of its bioanalytical and genetic testing businesses, and that it plans to continue its planned purchase of Shanghai-based peptide manufacturer GL Biochem.

CBI said it sold its testing businesses, CBI Services and Fairfax Identity Laboratory, to Bostwick Laboratories, a pathology lab company based in Richmond, Va., for a cash consideration and a five-year commitment to an ongoing property lease.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.